In a massive leap forward for cancer research, scientists at the University of California San Diego School of Medicine have harnessed the power of machine learning to confront one of the most daunting challenges in the field — predicting resistance to chemotherapy.
The groundbreaking study, unveiled on January 18, 2024, in the esteemed journal Cancer Discovery, introduces a sophisticated algorithm capable of deciphering the intricate interplay of genetic mutations within tumours, revolutionising our ability to anticipate how cancer will respond to treatment.
